PRESTIGE CONSMR (PBH)
(Delayed Data from NYSE)
$70.38 USD
-0.53 (-0.75%)
Updated Jul 24, 2024 04:00 PM ET
After-Market: $70.41 +0.03 (0.04%) 7:58 PM ET
4-Sell of 5 4
B Value D Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Prestige Consumer Healthcare Inc. [PBH]
Reports for Purchase
Showing records 181 - 200 ( 204 total )
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
2016 Consumer Conference featuring Convergence - Day 1 Highlights
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
PBH Posts Surprising Organic Sales Decline as Revenues Miss Consensus; EPS Beats
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Flossing Through Some Softer Sales Trends; Reiterate OW, New $56 PT
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Household Products/Personal Care: Previewing 3Q16 Earnings
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
No Dramamine Needed for Drug Channel Turbulence; Analysis Shows Little Impact to Sales, EPS
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
NDR with Management Leaves Us Positive on PBH
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Despite Some Particles Stuck in Org. Sales, DenTek Able to Floss Them Out to Deliver Solid Quarter
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Household Products/Personal Care: Previewing 2Q16 Earnings
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
PBH Announces Divestiture of 3 Non-Core OTC Healthcare Brands
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Analyst Day Gives Investors Clear Eyes Toward Solid LT Growth Story
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
4Q Beats Estimates Behind Core Portfolio Strength
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Momentum in Core OTC Portfolio Keeps Us Positive on Story
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Household Products/Personal Care: Will 1Q Results Prove That Defense Really Is the Best Offense?
Provider: KEYBANC CAPITAL MARKETS
Company: Prestige Consumer Healthcare Inc.
Industry: Consumer Products - Discretionary
Morning Meeting Notes
Provider: KEYBANC CAPITAL MARKETS